Evidence map›Paper›PMID 42635765›Full record

ArticleExperimental brain research2026

Levodopa-induced alterations in vertical center of mass and muscle synergy structure during Parkinsonian gait.

Rukiye Aydın, Genko Oyama, Shingo Shimoda, Alvaro Costa Garcia, Ken Kikuchi, Hiroyuki Hamada, Tomokazu Shimazu, Yoshihiro Kameyama, Kazunori Sato, Eriko Kitahara and 5 more

Abstract read
In one paragraph

Article in Experimental brain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rukiye AydınDepartment of Human and Engineered Environmental Studies, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8563, Japan.ORCID http://orcid.org/0009-0008-1795-3111
Genko OyamaDepartment of Neurology, Juntendo University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7985-5367
Shingo ShimodaGraduate School of Medicine, Nagoya University, Nagoya, Japan.ORCID http://orcid.org/0000-0002-7759-7541
Alvaro Costa GarciaResearch Institute On Human and Societal Augmentation, National Institute of Advanced Industrial Science and Technology (AIST), Kashiwa, Japan.ORCID http://orcid.org/0000-0003-0097-2793
Ken KikuchiDepartment of Human and Engineered Environmental Studies, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8563, Japan.ORCID http://orcid.org/0000-0002-0909-0968
Hiroyuki HamadaDepartment of Human and Engineered Environmental Studies, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8563, Japan.ORCID http://orcid.org/0000-0001-8213-961X
Tomokazu ShimazuDepartment of Neurology, Saitama Neuropsychiatric Institute, Saitama, Japan.ORCID http://orcid.org/0000-0001-9146-7770
Yoshihiro KameyamaDepartment of Neurology, Saitama Neuropsychiatric Institute, Saitama, Japan.
Kazunori SatoDepartment of Rehabilitation Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4292-3095
Eriko KitaharaDepartment of Rehabilitation Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0009-0008-9315-2682
Daiki KamiyamaDepartment of Neurology, Juntendo University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2179-4802
Atsushi YamashitaDepartment of Human and Engineered Environmental Studies, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8563, Japan.ORCID http://orcid.org/0000-0003-1280-069X
Toshiyuki FujiwaraDepartment of Rehabilitation Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1664-1745
Nobutaka HattoriDepartment of Neurology, Juntendo University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2034-2556
Qi AnDepartment of Human and Engineered Environmental Studies, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8563, Japan. anqi@robot.t.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0001-7641-2632

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by gait impairments that affect the regulation of whole-body movement, which can be quantified through metrics such as vertical center of mass (vCoM). In healthy gait, vCoM oscillations contribute to metabolic efficiency by facilitating the exchange between kinetic and potential energy; however, this mechanism is often disrupted in PD. Although levodopa improves motor impairments, its impact on vCoM and neuromuscular control remains poorly understood. This study investigated levodopa effects on vCoM and neuromuscular coordination in fifteen patients with PD (Hoehn & Yahr 2-3) during PD OFF (before levodopa) and PD ON (after levodopa) and compared to nine healthy older adults (HOA). Kinematic and electromyography data were collected during an overground walk to quantify vCoM and muscle synergies. Here we show that levodopa significantly increased maximum vCoM displacement (p = 0.002), with PD OFF showing significantly reduced displacement compared to HOA (p < 0.001) while PD ON did not differ significantly, indicating a shift in vCoM displacement towards healthy patterns. Temporal patterns of muscle synergies showed that PD OFF exhibited prolonged activation duration and slower slope-to-peak in Synergy 2 (push-off) compared to HOA while spatial patterns of Synergy 2 showed an increase in gastrocnemius muscle contribution in PD ON compared to PD OFF (p = 0.002). Together these findings demonstrate that levodopa might partially restore whole-body gait mechanics through a unique reorganization of muscle synergy structure, pointing to a possible functional link between neuromuscular coordination and gait dynamics in PD.

Indexed as

Antiparkinson AgentsGaitGait Disorders, NeurologicLevodopaMuscle, SkeletalParkinson DiseaseAgedBiomechanical PhenomenaElectromyographyFemaleHumansMaleMiddle AgedAntiparkinson AgentsLevodopaCenter-of-massMuscle synergyParkinson’s diseaseWearing-off

Identifiers

PMID42635765
PMCPMC13503391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.